Maleic Acid as a Co-Former for Pharmaceutically Active GABA Derivatives: Mechanochemistry or Solvent Crystallization?

In this study, we compare the mechanochemical and classical solvent crystallization methods for forming maleates of GABA and its pharmaceutically active derivatives: Pregabalin, Gabapentin, Phenibut, and Baclofen. Common characterization techniques, like powder and single crystal X-ray diffraction,...

Full description

Bibliographic Details
Main Authors: Daniel Komisarek, Ebru Taskiran, Vera Vasylyeva
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Materials
Subjects:
Online Access:https://www.mdpi.com/1996-1944/16/6/2242
_version_ 1797610501641863168
author Daniel Komisarek
Ebru Taskiran
Vera Vasylyeva
author_facet Daniel Komisarek
Ebru Taskiran
Vera Vasylyeva
author_sort Daniel Komisarek
collection DOAJ
description In this study, we compare the mechanochemical and classical solvent crystallization methods for forming maleates of GABA and its pharmaceutically active derivatives: Pregabalin, Gabapentin, Phenibut, and Baclofen. Common characterization techniques, like powder and single crystal X-ray diffraction, IR-spectroscopy, differential scanning calorimetry, thermogravimetric analysis and <sup>1</sup>H-NMR spectroscopy, are used for the evaluation of structural and physicochemical properties. Our work shows that maleate formation is possible with all investigated target compounds. Large increases in solubility can be achieved, especially for Pregabalin, where up to twentyfold higher solubility in its maleate compared to the pure form can be reached. We furthermore compare the mechanochemical and solvent crystallization regarding quickness, reliability of phase production, and overall product quality. A synthetic route is shown to have an impact on certain properties such as melting point or solubility of the same obtained products, e.g., for Gabapentin and Pregabalin, or lead to the formation of hydrates vs. anhydrous forms. For the GABA and Baclofen maleates, the method of crystallization is not important, and similarly, good results can be obtained by either route. In contrast, Phenibut maleate cannot be obtained pure and single-phase by either method. Our work aims to elucidate promising candidates for the multicomponent crystal formation of blockbuster GABA pharmaceuticals and highlight the usefulness of mechanochemical production routes.
first_indexed 2024-03-11T06:15:11Z
format Article
id doaj.art-43bb3a6100d943c1b6ceb3633eef2b7a
institution Directory Open Access Journal
issn 1996-1944
language English
last_indexed 2024-03-11T06:15:11Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Materials
spelling doaj.art-43bb3a6100d943c1b6ceb3633eef2b7a2023-11-17T12:19:29ZengMDPI AGMaterials1996-19442023-03-01166224210.3390/ma16062242Maleic Acid as a Co-Former for Pharmaceutically Active GABA Derivatives: Mechanochemistry or Solvent Crystallization?Daniel Komisarek0Ebru Taskiran1Vera Vasylyeva2Inorganic and Structural Chemistry I, Heinrich-Heine-University, 40225 Düsseldorf, GermanyInorganic and Structural Chemistry I, Heinrich-Heine-University, 40225 Düsseldorf, GermanyInorganic and Structural Chemistry I, Heinrich-Heine-University, 40225 Düsseldorf, GermanyIn this study, we compare the mechanochemical and classical solvent crystallization methods for forming maleates of GABA and its pharmaceutically active derivatives: Pregabalin, Gabapentin, Phenibut, and Baclofen. Common characterization techniques, like powder and single crystal X-ray diffraction, IR-spectroscopy, differential scanning calorimetry, thermogravimetric analysis and <sup>1</sup>H-NMR spectroscopy, are used for the evaluation of structural and physicochemical properties. Our work shows that maleate formation is possible with all investigated target compounds. Large increases in solubility can be achieved, especially for Pregabalin, where up to twentyfold higher solubility in its maleate compared to the pure form can be reached. We furthermore compare the mechanochemical and solvent crystallization regarding quickness, reliability of phase production, and overall product quality. A synthetic route is shown to have an impact on certain properties such as melting point or solubility of the same obtained products, e.g., for Gabapentin and Pregabalin, or lead to the formation of hydrates vs. anhydrous forms. For the GABA and Baclofen maleates, the method of crystallization is not important, and similarly, good results can be obtained by either route. In contrast, Phenibut maleate cannot be obtained pure and single-phase by either method. Our work aims to elucidate promising candidates for the multicomponent crystal formation of blockbuster GABA pharmaceuticals and highlight the usefulness of mechanochemical production routes.https://www.mdpi.com/1996-1944/16/6/2242solubilitycrystal engineeringmechanochemistrycrystal synthesis
spellingShingle Daniel Komisarek
Ebru Taskiran
Vera Vasylyeva
Maleic Acid as a Co-Former for Pharmaceutically Active GABA Derivatives: Mechanochemistry or Solvent Crystallization?
Materials
solubility
crystal engineering
mechanochemistry
crystal synthesis
title Maleic Acid as a Co-Former for Pharmaceutically Active GABA Derivatives: Mechanochemistry or Solvent Crystallization?
title_full Maleic Acid as a Co-Former for Pharmaceutically Active GABA Derivatives: Mechanochemistry or Solvent Crystallization?
title_fullStr Maleic Acid as a Co-Former for Pharmaceutically Active GABA Derivatives: Mechanochemistry or Solvent Crystallization?
title_full_unstemmed Maleic Acid as a Co-Former for Pharmaceutically Active GABA Derivatives: Mechanochemistry or Solvent Crystallization?
title_short Maleic Acid as a Co-Former for Pharmaceutically Active GABA Derivatives: Mechanochemistry or Solvent Crystallization?
title_sort maleic acid as a co former for pharmaceutically active gaba derivatives mechanochemistry or solvent crystallization
topic solubility
crystal engineering
mechanochemistry
crystal synthesis
url https://www.mdpi.com/1996-1944/16/6/2242
work_keys_str_mv AT danielkomisarek maleicacidasacoformerforpharmaceuticallyactivegabaderivativesmechanochemistryorsolventcrystallization
AT ebrutaskiran maleicacidasacoformerforpharmaceuticallyactivegabaderivativesmechanochemistryorsolventcrystallization
AT veravasylyeva maleicacidasacoformerforpharmaceuticallyactivegabaderivativesmechanochemistryorsolventcrystallization